Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?

ISSN： 1750-743X

Source： Immunotherapy, Vol.5, Iss.5, 2013-05, pp. : 441-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

By Sarno Maria Anna Mancari Rosanna Azim Hatem A Colombo Nicoletta Peccatori Fedro A

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 733-741

Future Medicine

Access to resources Recommend Favorite

Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

By Kiss Emese

Clinical Reviews in Allergy and Immunology, Vol. 32, Iss. 1, 2007-02 ,pp. : 37-46

Humana Press, Inc

Access to resources Recommend Favorite

Treatment of autoimmune disease: time for a paradigm shift?

By Mor Felix

Archivum Immunologiae et Therapiae Experimentalis, Vol. 55, Iss. 1, 2007-02 ,pp. : 13-18

Springer Publishing Company

Access to resources Recommend Favorite

Crimean-Congo Hemorrhagic Fever Virus

Current Molecular Medicine, Vol. 5, Iss. 8, 2005-12 ,pp. : 753-760

Bentham Science Publishers

Access to resources Recommend Favorite

Was it justified?

By Heron John

Australasian Physical & Engineering Sciences in Medicine, Vol. 34, Iss. 1, 2011-04 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite